Similarly, in estrogen receptor-positive (ESR+) human breast cancer cells lines (T47D, BT474 and MCF7), ANKLE2 overexpression contributes to tamoxifen resistance and accelerated tumor growth (Gao et al., 2018). This evidence concerns the gene ANKLE2 and breast carcinoma.